Annual Current Liabilities
$1.25 B
+$1.09 B+676.82%
December 31, 2024
Summary
- As of February 26, 2025, RPRX annual total current liabilities is $1.25 billion, with the most recent change of +$1.09 billion (+676.82%) on December 31, 2024.
- During the last 3 years, RPRX annual current liabilities has risen by +$1.08 billion (+632.04%).
- RPRX annual current liabilities is now at all-time high.
Performance
RPRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.25 B
+$85.86 M+7.35%
December 31, 2024
Summary
- As of February 26, 2025, RPRX quarterly total current liabilities is $1.25 billion, with the most recent change of +$85.86 million (+7.35%) on December 31, 2024.
- Over the past year, RPRX quarterly current liabilities has increased by +$1.09 billion (+676.82%).
- RPRX quarterly current liabilities is now at all-time high.
Performance
RPRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RPRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +676.8% | +676.8% |
| 3 y3 years | +632.0% | +676.8% |
| 5 y5 years | +276.0% | +676.8% |
RPRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +676.8% | at high | +906.3% |
| 5 y | 5-year | at high | +676.8% | at high | +906.3% |
| alltime | all time | at high | +676.8% | at high | +906.3% |
Royalty Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.25 B(+676.8%) | $1.25 B(+7.4%) |
| Sep 2024 | - | $1.17 B(+323.6%) |
| Jun 2024 | - | $275.70 M(+121.3%) |
| Mar 2024 | - | $124.57 M(-22.8%) |
| Dec 2023 | $161.38 M(-86.2%) | $161.38 M(+26.1%) |
| Sep 2023 | - | $127.93 M(-89.1%) |
| Jun 2023 | - | $1.17 B(+5.0%) |
| Mar 2023 | - | $1.12 B(-4.3%) |
| Dec 2022 | $1.17 B | $1.17 B(+3.1%) |
| Sep 2022 | - | $1.13 B(+520.7%) |
| Jun 2022 | - | $182.33 M(+34.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $135.87 M(-20.7%) |
| Dec 2021 | $171.25 M(-44.4%) | $171.25 M(-32.9%) |
| Sep 2021 | - | $255.06 M(-10.2%) |
| Jun 2021 | - | $283.99 M(+10.9%) |
| Mar 2021 | - | $255.98 M(-16.9%) |
| Dec 2020 | $307.89 M(-7.7%) | $307.89 M(+14.0%) |
| Sep 2020 | - | $269.98 M(-40.1%) |
| Jun 2020 | - | $450.97 M(+3.9%) |
| Mar 2020 | - | $433.96 M(+30.2%) |
| Dec 2019 | $333.42 M(-42.5%) | $333.42 M |
| Dec 2018 | $580.17 M | - |
FAQ
- What is Royalty Pharma annual total current liabilities?
- What is the all time high annual current liabilities for Royalty Pharma?
- What is Royalty Pharma annual current liabilities year-on-year change?
- What is Royalty Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Royalty Pharma?
- What is Royalty Pharma quarterly current liabilities year-on-year change?
What is Royalty Pharma annual total current liabilities?
The current annual current liabilities of RPRX is $1.25 B
What is the all time high annual current liabilities for Royalty Pharma?
Royalty Pharma all-time high annual total current liabilities is $1.25 B
What is Royalty Pharma annual current liabilities year-on-year change?
Over the past year, RPRX annual total current liabilities has changed by +$1.09 B (+676.82%)
What is Royalty Pharma quarterly total current liabilities?
The current quarterly current liabilities of RPRX is $1.25 B
What is the all time high quarterly current liabilities for Royalty Pharma?
Royalty Pharma all-time high quarterly total current liabilities is $1.25 B
What is Royalty Pharma quarterly current liabilities year-on-year change?
Over the past year, RPRX quarterly total current liabilities has changed by +$1.09 B (+676.82%)